image credit: Adobe Stock

Osmind Secures $40M to Expand Mental Health EHR Platform

May 10, 2022


Osmind helps the medical community administer, track, and study the efficacy of interventions such as ketamine, SPRAVATO, and transcranial magnetic stimulation for the 14 million U.S. patients living with moderate and serious mental illness. Osmind is applying its funding to continue to develop and scale its market-leading electronic health record (EHR) technology for breakthrough mental health research and treatment, advance research with new partners, and double the size of the team virtually and at the company’s San Francisco office.

Read More on HitConsultant